| Q28078766 | "Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors |
| Q79831895 | Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure |
| Q37212200 | Adrenergic receptors and metabolism: role in development of cardiovascular disease |
| Q41969432 | Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity. |
| Q40968701 | Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study |
| Q37067437 | Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment |
| Q99553601 | Antidepressant treatment in patients following acute coronary syndromes: a systematic review and Bayesian meta-analysis |
| Q36252811 | Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure |
| Q35954702 | Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? |
| Q35645970 | Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe Asthma |
| Q34479755 | Dynamic changes in lymphocyte GRK2 levels in cardiac transplant patients: a biomarker for left ventricular function. |
| Q38172127 | Effects of exercise training on cardiovascular adrenergic system |
| Q37265891 | Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction |
| Q42111941 | Endothelial G protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species |
| Q37700344 | Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients |
| Q54978112 | Exploring the relationship between β-adrenergic receptor kinase-1 and physical symptoms in heart failure. |
| Q47740257 | G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling. |
| Q30487539 | G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure |
| Q35041039 | G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. |
| Q64376683 | G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart |
| Q37349411 | G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans |
| Q35757227 | G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity |
| Q27014769 | G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism |
| Q37881660 | G protein-coupled receptor kinases in normal and failing myocardium |
| Q26786233 | G-protein-coupled receptor kinase 2 and endothelial dysfunction: molecular insights and pathophysiological mechanisms |
| Q38093493 | G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms |
| Q35528402 | G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart |
| Q37229933 | GRK 2 level in peripheral blood lymphocytes of elderly patients with acute myocardial infarction |
| Q58651672 | GRK2 Levels in Umbilical Arteries of Pregnancies Complicated by Gestational Hypertension and Preeclampsia |
| Q35660111 | GRK2 and β-arrestins in cardiovascular disease: Something old, something new. |
| Q37783642 | GRK2 as a novel gene therapy target in heart failure. |
| Q36399800 | GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels |
| Q36760778 | GRK2 in Lymphocytes: Expanding the Arsenal of Heart Failure Prognostics. |
| Q90648916 | GRK2 knockdown in mice exacerbates kidney injury and alters renal mechanisms of blood pressure regulation |
| Q34644069 | GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity |
| Q35766985 | Gi-biased β2AR signaling links GRK2 upregulation to heart failure |
| Q41903711 | Growth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2. |
| Q42772150 | Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction |
| Q37416728 | Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation |
| Q38848001 | Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy |
| Q36632453 | Kinase inhibitors for cardiovascular disease |
| Q90682467 | Loss of Dynamic Regulation of G Protein-Coupled Receptor Kinase 2 by Nitric Oxide Leads to Cardiovascular Dysfunction with Aging |
| Q36699897 | Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure |
| Q37108942 | Molecular Mechanisms Linking Autonomic Dysfunction and Impaired Cardiac Contractility in Critical Illness |
| Q36651023 | Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases |
| Q58790122 | New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging |
| Q26776138 | Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood Leukocytes |
| Q48413482 | Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions |
| Q36623426 | Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction |
| Q35033114 | Perturbed atrial calcium handling in an ovine model of heart failure: potential roles for reductions in the L-type calcium current |
| Q82259243 | Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor |
| Q36757784 | Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure |
| Q37123741 | Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling |
| Q33876021 | Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support |
| Q37964927 | Reverse remodeling in heart failure--mechanisms and therapeutic opportunities |
| Q33168540 | RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism |
| Q39960934 | Sociology meets genetics: sociogenetic implications for future management of hypertension and heart failure |
| Q37831634 | Taking the heart failure battle inside the cell: small molecule targeting of Gβγ subunits |
| Q39107039 | Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies |
| Q37702799 | The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease |
| Q37768803 | The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets |
| Q36000382 | The evolving impact of g protein-coupled receptor kinases in cardiac health and disease |
| Q30250314 | The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development |
| Q90627725 | The impact of high-intensity interval training on ventricular remodeling in patients with a recent acute myocardial infarction-A randomized training intervention pilot study |
| Q26865721 | Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization |
| Q37036343 | Uncoupling of myocardial beta-adrenergic receptor signaling during coronary artery bypass grafting: the role of GRK2. |
| Q37551918 | β-Adrenergic Receptor and Insulin Resistance in the Heart |
| Q37453620 | β-adrenergic receptor responsiveness in aging heart and clinical implications |
| Q64229703 | β2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation |